The largest database of trusted experimental protocols
> Disorders > Pathologic Function > Postpartum Hemorrhage

Postpartum Hemorrhage

Postpartum Hemorrhage is a serious complication that can occur after childbirth, characterized by excessive bleeding from the uterus.
This life-threatening condition requires prompt medical intervention to control the bleeding and prevent complications.
PubCompare.ai's AI-driven protocols can help optimize your research on Postpartum Hemorrhage by easily locating the best protocols and products from literature, preprints, and patents using their AI-powered comparisons.
Streamline your research process and uncover the most relevant information with PubCompare.ai to better understand and manage this critical maternal health issue.

Most cited protocols related to «Postpartum Hemorrhage»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2013
Antibiotics Apgar Score Blood Transfusion Cellulitis Chorioamnionitis Clavicle Committee Members Deep Vein Thrombosis Endometritis Forceps Fracture, Bone Hemorrhage Hospitalization Hypoxic-Ischemic Encephalopathy Hysterectomy Infant Infant, Newborn Infection Laceration Mothers Obstetric Delivery Paralysis, Facial Perineum Placenta Accreta Placenta Previa Plexus, Brachial Postpartum Hemorrhage Pregnancy Pulmonary Embolism Shoulder Dystocia Skeleton Vacuum Vagina Venous Thromboembolism Ventilation-Perfusion Scan Woman Wounds X-Ray Computed Tomography
Between August 2002 to December 2008, 1,823 VA questionnaires were reviewed by physicians who assigned a COD to each case. The required indicators from each of these questionnaires were extracted and entered into the InterVA model to automatically generate COD.
There are a total of 60 possible causes of death assigned by physicians, while the InterVA model only assigns 27 causes (see additional file 1). Therefore, to allow for meaningful comparison between physicians and the model, we re-categorized all causes in both methods into 14 main groups of causes for two reasons. First, we took this step to have comparable cause of death categories between both methods being analyzed. Where possible, we retained the categories common to both methods. For instance, malaria and meningitis, which are common to both physician review and InterVA, were retained as stand-alone causes. In cases where there were no direct correlates, we had to collapse and/or re-categorize the causes of death into cause groups to match each other in a broad sense. For instance, the InterVA model has only one broad category of maternity-related deaths representing all types of pregnancy-related deaths. However, the physicians coded causes such as eclampsia and ante-partum and post-partum hemorrhage. Such causes were therefore recoded into one broad category of maternity-related deaths so we could compare with the corresponding InterVA category. Frequently occurring conditions, such as pulmonary tuberculosis, HIV/AIDS, and pneumonia, were left as stand-alone causes. Second, it was more important to us that the model and the physicians arrived at broad agreement in identifying cause of death groups with the greatest public health importance at population level, rather than individual-level causes. Hence, causes such as kidney disease and cancers were recoded as chronic diseases, while causes such as rabies, tetanus, and typhoid were grouped into other acute/infectious diseases.
We then determined the cause-specific mortality fractions (CSMF) of using the InterVA model and physician review. We conducted our analysis for the general population and by two main age groups: children aged less than 5 years and for adults aged 18 years and older. While it is possible to conduct the analysis across various age categories, we decided to focus on the under-5 and adult deaths due to high levels of mortality in these age groups from preventable conditions such as diarrheal disease and HIV/AIDS, respectively [34 (link)]. Such preventable conditions are of great public health significance, especially in developing countries. Thereafter, we estimated the level of agreement between InterVA and physician-assigned COD using Kappa statistics. All analyses were carried out using STATA version 10 statistical software. In all our analyses, we only considered the most probable COD assigned by the model rather than all three possible causes. This is because the COD assigned by the physicians included only a single cause of death.
Publication 2010
Acquired Immunodeficiency Syndrome Adult Age Groups Child Communicable Diseases Diarrhea Disease, Chronic Eclampsia Kidney Kidney Diseases Malaria Malignant Neoplasms Meningitis Physicians Pneumonia Postpartum Hemorrhage Pregnancy Rabies Vaccines Shock Toxoid, Tetanus Tuberculosis, Pulmonary Typhoid Fever
The primary outcome of the trial was the incidence of postpartum haemorrhage, defined by a blood loss of ≥500 mL, measured with a graduated collector bag.25 (link) The main secondary outcomes were other objective measures of postpartum bleeding: measured blood loss ≥1000 mL at bag removal, mean measured blood loss at 15 minutes after birth (the bag had to be left in place at least 15 minutes to have one measure of blood loss at the same time point in all women), mean measured postpartum blood loss at bag removal, and mean changes in peripartum haemoglobin level and haematocrit (difference between haemoglobin level and haematocrit before delivery and at day 2 postpartum). Other secondary outcomes included use of supplementary uterotonic treatment; postpartum transfusion (until discharge); arterial embolisation or emergency surgery for postpartum haemorrhage; other characteristics of the third stage, including duration, manual removal of the placenta; and women’s experience of the third stage, assessed by a self administered questionnaire on day 2 postpartum. Safety outcomes included uterine inversion, cord rupture, and pain.
The detail of procedures used to manage the third stage, as well as all clinical outcomes identified during the immediate postpartum period, were prospectively collected by the midwife or obstetrician in charge of the delivery and recorded in the woman’s electronic form in the labour room. Other data were collected by a research assistant, independent of the local medical team. An independent data monitoring committee, which met monthly, was responsible for reviewing adherence to the trial procedures, recruitment, and safety data; the quality of collected outcome data was checked in each centre for 10% of the included women, randomly selected, and in all cases of postpartum haemorrhage.
Publication 2013
Arteries Blood Transfusion Childbirth Cone-Rod Dystrophy 2 Embolization, Therapeutic Emergencies Hemoglobin Hemorrhage Midwife Obstetric Delivery Obstetrician Operative Surgical Procedures Pain Patient Discharge Placenta Postpartum Hemorrhage Safety Uterine Inversion Volumes, Packed Erythrocyte Woman
The primary outcome was a composite of peri-natal death or severe neonatal complications and consisted of one or more of the following during the antepartum or intrapartum period or during the delivery hospitalization: perinatal death, the need for respiratory support within 72 hours after birth, Apgar score of 3 or less at 5 minutes, hypoxic–ischemic encephalopathy,17 (link) seizure, infection (confirmed sepsis or pneumonia), meconium aspiration syndrome, birth trauma (bone fracture, neurologic injury, or retinal hemorrhage), intracranial or subgaleal hemorrhage, or hypo-tension requiring vasopressor support. The principal prespecified maternal outcome (the main secondary outcome) was cesarean delivery.
Prespecified subgroups for the primary perinatal outcome and for the secondary outcome of cesarean delivery were maternal race or ethnic group as reported by the participant (white, black, Asian, Hispanic, other, unknown, or more than one race), age of 35 years or older versus younger than 35 years, body-mass index (the weight in kilograms divided by the square of the height in meters) of 30 or more versus less than 30, and a modified Bishop score at the time of randomization of less than 5 versus 5 or higher. In addition, although it was not a baseline variable, the specialty of the admitting provider (obstetrics-gynecology, maternal-fetal medicine, family practice, or midwifery) was prespecified for the subgroup analyses.
Neonatal secondary outcomes included birth weight, duration of respiratory support, cephalohematoma, shoulder dystocia, transfusion of blood products, hyperbilirubinemia requiring photo-therapy or exchange transfusion, hypoglycemia requiring intravenous therapy, admission to the neonatal intermediate or intensive care unit, and length of hospitalization. In addition to cesarean delivery, other maternal secondary outcomes included hypertensive disorders of pregnancy (gestational hypertension or preeclampsia), indication for cesarean delivery, operative vaginal delivery, indication for operative vaginal delivery, uterine incisional extensions during cesarean delivery, chorioamnionitis, third-degree or fourth-degree perineal laceration, postpartum hemorrhage, postpartum infection, venous thromboembolism, number of hours in the labor and delivery unit, length of postpartum hospital stay, admission to the intensive care unit, and maternal death. Definitions of secondary outcomes are provided in the Supplementary Appendix.
Records of all infants who met the primary perinatal outcome were reviewed centrally to verify that the primary outcome had occurred. Records of infants in whom the primary outcome did not occur but that suggested (on the basis of a delivery hospitalization of 7 or more days or discharge to a long-term care facility) that clinically significant perinatal complications may have occurred were reviewed centrally as well. Reviewers were unaware of the trial-group assignments.
Publication 2018
Apgar Score Asian Persons Birth Birth Injuries Birth Weight Blood Transfusion Cesarean Section Chorioamnionitis Ethnicity Exchange Transfusion, Whole Blood Fracture, Bone Hemorrhage High Blood Pressures Hispanics Hospitalization Hyperbilirubinemia Hypoglycemia Hypoxic-Ischemic Encephalopathy Index, Body Mass Infant Infant, Newborn Infection Laceration Maternal Death Meconium Aspiration Syndrome Mothers Obstetric Delivery Obstetric Labor Patient Discharge Perineum Pneumonia Postpartum Hemorrhage Pre-Eclampsia Pregnancy Puerperal Infection Respiratory Rate Retinal Hemorrhage Seizures Septicemia Shoulder Dystocia Therapeutics Transient Hypertension, Pregnancy Trauma, Nervous System Uterus Vagina Vasoconstrictor Agents Venous Thromboembolism Youth
A prospective cohort study was implemented in the Western Province of Rwanda between September 2010 and September 2011, with two intervention health posts and one control health post. Currently, the health post is the lowest level of the healthcare infrastructure where women can receive ambulatory level reproductive healthcare services and the health center is the lowest level where women in labor receive care (intrapartum services). At one intervention health post, ambulatory care was thus further decentralized from the health post to the village level, with a mobile nurse providing in-home comprehensive reproductive health care. This nurse worked closely with the community health workers to organize this village-level health care service. At least one or two of these community workers, who live and work in every village in Rwanda, are responsible for assisting all pregnant women in attending their prenatal care appointments and accompanying them to a health care facility at the time of labor.
At the second intervention health post, intrapartum care was further decentralized from the local health center to the level of the health post. This was accomplished by the opening of a maternity center where women in labor could deliver their babies. This center was staffed by trained nurses and referral services were established to the district hospital for high risk cases. No changes to services were made at the control site for the study.
Convenience sampling of all pregnant women living in the catchment areas of the three health posts was performed. Women receiving ANC at any of these sites were eligible for inclusion. At the control site and the decentralized intrapartum site, all women presenting for ANC were individually educated about the study and recruited to participate. A study nurse consented the women who agreed to participate in the study. At the decentralized ambulatory care site, women willing to participate received group education in the villages by the mobile nurse followed by individual written informed consent. After delivery, data were abstracted from the existing ANC charts, partographs, and intrapartum charts.
The primary outcome of interest was lack of SAB. Secondary outcome was having at least three ANC visits. SAB was defined as receiving intrapartum and postpartum care by a nurse, midwife, or physician at a health center, district hospital, or at the study health post with decentralized intrapartum care. Data on the following maternal and neonatal outcomes were also gathered: intra-partum hemorrhage, post-partum hemorrhage, obstetric fistulae, intrapartum or postpartum fever, retained placenta, eclampsia, hysterectomy, maternal death, admission to the neonatal intensive care unit, perinatal death, neonatal sepsis.
Two distance variables were defined. Village-delivery site distance was defined as the average number of minutes it takes to walk from village to delivery site. Village-ANC site distance was defined as the average number of minutes it takes to walk from village to ANC site.
Associations of socio-demographic and distance variables with the two outcomes were evaluated using Chi-square and ANOVA tests for categorical and continuous variables, respectively. Number of ANC visits was dichotomized at the median to greater than or equal to three visits. Chi-square was used to evaluate bivariate associations between the above defined outcome variables and intervention site. A Chi-square test was also done to evaluate the association between number of ANC visits and having no SAB. Adverse outcomes were dichotomized and bivariate tests were done to evaluate for associations with the outcome variables of interest and intervention site.
Backward stepwise multivariate logistic regression analysis was performed for predicting the factors associated with the two outcomes of interest. Simultaneous evaluation for confounding was done to create an appropriately adjusted model that best fit the data. Statistical analyses were done using STATA software, version 11 (College Station, TX: StataCorp, LP). Two-sided tests were used, with statistical significance defined as having p<0.05.
The Rwandan National Ethics Committee and the Institutional Review Board at Albert Einstein College of Medicine/Montefiore Medical Center approved this study.
Publication 2015
Care, Ambulatory Care, Prenatal Community Health Workers Eclampsia Ethics Committees Ethics Committees, Research Fever Fistula Hemorrhage Hysterectomy Infant Infant, Newborn Maternal Death Midwife neuro-oncological ventral antigen 2, human Nurses Obstetric Delivery Obstetric Labor Pharmaceutical Preparations Physicians Placenta, Retained Postnatal Care Postpartum Hemorrhage Pregnant Women Reproductive Health Services Sepses, Neonatal Woman Workers

Most recents protocols related to «Postpartum Hemorrhage»

The protocol for this study was approved by the Ethics Committee of the Japanese Red Cross Katsushika Maternity Hospital in 2021 (K2021-29).
This was a retrospective study of primiparous singleton pregnancies who delivered at ≥22 weeks of gestation managed at Japanese Red Cross Katsushika Maternity Hospital between 2003-2007 and 2013-2017. In some literature, age more than 35 years may be considered under high-risk pregnancy [2 (link),3 (link)]; however, in this study, we defined 40 years or older as AMA because more than 30% of women undergoing fertility treatment in Japan have started the treatment after the age of 40 [9 ]. The periods were chosen because there were no institute relocations or renovations, and there were no restrictions on the acceptance of medical care, so it was thought that there would be no bias in data collection. A flow diagram of study inclusion is shown in Figure 1. In this study, the obstetric and perinatal outcomes in the Japanese primiparous women aged 40 years and older at delivery in 2013-2017 (n=542: recent AMA group) were compared with those in 2003-2007 (n=174: previous AMA group).
Data included antenatal data, gestational age at delivery, mode of delivery, birth weight, Apgar score at one and five minutes, neonatal intensive care unit (NICU) admission, neonatal death, and postpartum hemorrhage.
During these two periods, there were not any significant changes in the medical situation of the NICU in our institute.
Perinatal death was defined as intrauterine fetal demise at ≥22 weeks' gestation, stillbirth with the fetus weighing 500 g, and neonatal death in the first week of life. Neonatal asphyxia was defined as a neonatal Apgar score at one or five minutes of <7. Postpartum hemorrhage was defined as an estimated blood loss of ≥1,000 mL. Preterm delivery was defined as delivery at <37 weeks' gestation. In most cases, the gestational age was defined based on ultrasonography at 9-11 weeks of gestation. In cases with a delayed first visit, the gestational age was confirmed based on a neonatal neurological assessment.
Data are expressed as average and number (percentage). SPSS Statistics software version 20 (IBM Inc., Armonk, New York) was used for statistical analyses. A test of normality between the two groups was also performed. For statistical analysis, the χ2 test for categorical variables was used. Student's t-test was used for continuous variables. A p-value of <0.05 was considered significant. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. To examine the antenatal data with obstetric and perinatal outcomes, a multivariate logistic regression analysis was conducted.
Publication 2023
Apgar Score Asphyxia Neonatorum Birth Weight Ethics Committees, Clinical Fertility Fetus Gestational Age Hemorrhage High-Risk Pregnancy Infant, Newborn Japanese Neonatal Screening Obstetric Delivery Postpartum Hemorrhage Pregnancy Premature Birth Ultrasonography Woman
The reported data utilized material obtained during a recently published study investigating the effect of Na2S2O3 in a long-term porcine model of hemorrhage (5 (link)). Experiments were conducted according to the National Institutes of Health Guidelines on the Use of Laboratory Animals and the European Union ‘Directive 2010/63 EU on the protection of animals used for scientific purposes’ after approval by the University of Ulm Animal Care Committee and the Federal Authorities for Animal Research (Regierungspräsidium Tübingen, Germany, Reg.-Nr. 1341, date of approval 02.05.2017). A total of 17 adult Bretoncelles-Meishan-Willebrand (BMW) pigs of both sexes (7 castrated males, 10 females) with a median weight of 62 kg (interquartile range (IQR) 56;67) and a median age of 15 months (IQR 13;16) were included in this study. The STS group included 4/5 male-castrated/female pigs and the vehicle control group consisted of 3/5 male-castrated/female animals. The BMW strain is characterized by a decreased activity of the von Willebrand factor resulting in a coagulatory state similar to that of human blood (45 (link), 46 (link)).
Publication 2023
Adult Animal Care Committees Animals Animals, Laboratory BLOOD Coagulation, Blood Factor VIII-Related Antigen Females Homo sapiens Males Pigs Postpartum Hemorrhage Strains
All women were grouped according to three bases: age, parity, and a mixture of age and parity. According to age, pregnant women were divided into five groups: the first appropriate age group (20–24 years, A1 group), the second appropriate age group (25–29 years, A2 group), the third appropriate age group (30–34 years, A3 group), the advanced maternal age group (35–39 years old, AMA group), and the very advanced maternal age group (≥40 years, vAMA group). For parity, pregnant women were divided into two groups: a nulliparous group (parity = 1) and a multiparous group (parity ≥ 2). With regard to the mixture of age and parity, pregnant women were divided into 10 groups, combining the two previous groupings. Education was categorized into bachelor’s degree or above and no bachelor’s degree. Residence was divided into urban and rural areas. Marital status was divided into married and unmarried. Smoking was divided into Yes and No. Pre-pregnancy BMI was calculated by dividing pre-pregnancy weight (kg) by the square of height (m2). BMI was divided into four categories using Asian-specific cut-offs (17 (link)): <18.5, 18.5–23, 23–27.5, and ≥27.5 kg/m2. Gestational weight gain (GWG) was classified following the 2009 Institute of Medicine (IOM) guidelines, the standard divides GWG into Inadequate, Adequate, and Excessive according to different prenatal weight standards for pregnant women (18 ). Pregnancy was divided into two categories: assisted reproduction and natural conception. Gestational weeks were separated into three categories: 28–31, 32–36, and 37 weeks and above, with deliveries at less than 37 weeks being considered as preterm births. For multiparas, the form of the previous birth was classified into cesarean section and vaginal delivery.
The outcome indicators were maternal pregnancy outcomes and neonatal outcomes. Maternal pregnancy outcomes included gestational hypertension, eclampsia/pre-eclampsia, gestational diabetes mellitus (GDM), intrahepatic cholestasis of pregnancy (ICP), anemia, placenta previa, placental abruption, placental implantation, premature rupture of membranes, postpartum hemorrhage, oligohydramnios, preterm birth, and cesarean section. Neonatal outcomes included macrosomia, fetal distress, transfer to the neonatal unit, neonatal jaundice, and an Apgar score <7 within 5 min of birth. All outcome indicators were diagnosed according to the International Classification of Diseases 10th edition (ICD-10).
Publication 2023
Abruptio Placentae Age Groups Anemia Apgar Score Asian Persons Birth Cesarean Section Conception Eclampsia Fetal Distress Fetal Membranes, Premature Rupture Gestational Diabetes Infant, Newborn Intrahepatic Cholestasis of Pregnancy Mothers Neonatal Jaundice Obstetric Delivery Oligohydramnios Ovum Implantation Placenta Placenta Previa Postpartum Hemorrhage Pregnancy Pregnant Women Premature Birth Reproduction Transient Hypertension, Pregnancy Vagina Woman
Maternal baseline information was derived from the electronic database of the hospitals, including sociodemographic characteristics and reproductive history. We further abstracted the ART procedures and most of the perinatal outcomes from the database of the hospitals, while the neonatal morbidity and mortality were followed up and recorded by well-trained clinical personnel. The pregnancy outcomes assessed included hypertensive disorders in pregnancy (HDP), GDM, Intrahepatic cholestasis of pregnancy (ICP), placental abruption, placenta previa, oligohydramnios, premature rupture of membrane (PROM), postpartum hemorrhage (PPH) and mode of delivery. While neonatal outcomes were assessed including the gender of neonates, birth weight, preterm birth (PTB), weight for gestational age, neonatal infection, admission to the neonatal intensive care unit (NICU), neonatal asphyxia, neonatal jaundice, and congenital anomaly. Preterm birth was defined as delivery at less than 37 weeks, and very preterm was defined as delivery of baby between 28 and 32 gestational weeks of pregnancy. LGA or SGA was defined as a birth weight more than 90th centile or less than 10th centile of our population for a specific gestational age and sex, respectively (19 (link), 20 (link)). Diagnoses were coded according to the International Classification of Diseases version 10(ICD-10).
Publication 2023
Abruptio Placentae Asphyxia Neonatorum Birth Weight Conditioning, Psychology Congenital Abnormality Diagnosis Fetal Membranes, Premature Rupture Gestational Age High Blood Pressures Infant Infant, Newborn Infection Intrahepatic Cholestasis of Pregnancy Mothers Neonatal Jaundice Obstetric Delivery Oligohydramnios Placenta Previa Postpartum Hemorrhage Pregnancy Premature Birth
All demographic data regarding FET cycles were collected from our fertility center’s EMRs. The obstetric and neonatal complications were obtained from the EMR system in the Department of Obstetrics of our hospital. Live birth was defined as a fetus born alive after 28 weeks of pregnancy. The primary aim was to examine obstetric outcomes, specifically the incidence of gestational hypertension. The four categories of HDP were preeclampsia, gestational hypertension, superimposed preeclampsia, and chronic hypertension. Gestational hypertension was defined as hypertension after 20 weeks of gestational age without proteinuria. Additional obstetric outcomes that were examined included gestational diabetes, premature rupture of membranes (PROM, beyond 37 weeks of gestation and prior to the onset of labor), preterm premature rupture of membranes (PPROM, rupture of membranes prior to 37 weeks of gestation), placenta previa, placenta accreta, abnormal umbilical cord, polyhydramnios, oligohydramnios, postpartum hemorrhage (estimated blood loss ≥ 500 mL in a vaginal delivery or ≥ 1000 mL in a cesarean delivery), and cesarean delivery. The spectrum of abnormal umbilical cord includes the following types: presentation of umbilical cord, torsion of cord, excessively long cord, true knot, and abnormal insertion (e.g., vasa previa, battledore placenta, and velamentous insertion).
Publication 2023
Cesarean Section Childbirth Cone-Rod Dystrophy 2 Fertility Fetal Membranes, Premature Rupture Fetus Gestational Age Gestational Diabetes High Blood Pressures Infant, Newborn Obstetric Delivery Oligohydramnios Placenta Placenta Accreta Placenta Previa Polyhydramnios Postpartum Hemorrhage Pre-Eclampsia Pregnancy Preterm Premature Rupture of the Membranes Tissue, Membrane Transient Hypertension, Pregnancy Umbilical Cord Vaginal Bleeding Vasa Previa

Top products related to «Postpartum Hemorrhage»

Sourced in United States
SAS for Windows is a software application that provides statistical analysis and data management capabilities for Windows-based computers. It offers a comprehensive suite of tools for data manipulation, analysis, and visualization. The core function of SAS for Windows is to enable users to efficiently manage, analyze, and interpret their data.
Sourced in United States
The Spectronix 3000 is a spectrophotometer designed for laboratory applications. It measures the absorption or transmission of light through a sample, providing data on the sample's composition and properties. The device operates within a specific range of the electromagnetic spectrum, allowing for the analysis of various materials and substances.
Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in United States, United Kingdom, Denmark, Spain, Austria, Canada, Israel
STATA version 12 is a general-purpose statistical software package developed by StataCorp. It is designed for data analysis, management, and visualization. STATA version 12 provides a wide range of statistical tools and techniques for various applications, including regression analysis, time-series analysis, and survey data analysis.
Sourced in United States, United Kingdom, Austria, Denmark
Stata 15 is a comprehensive, integrated statistical software package that provides a wide range of tools for data analysis, management, and visualization. It is designed to facilitate efficient and effective statistical analysis, catering to the needs of researchers, analysts, and professionals across various fields.
Sourced in United States
Epi Info version 7 is a free, public domain software package designed for the Microsoft Windows operating system. It is developed by the Centers for Disease Control and Prevention (CDC) for the purpose of data entry, data management, and epidemiological analysis.
Sourced in United States, Denmark, United Kingdom
STATA version 11 is a software package for statistical analysis, data management, and graphics. It provides a wide range of statistical tools and functions for researchers, analysts, and professionals in various fields. The core function of STATA version 11 is to perform advanced statistical analysis and modeling on data.
Sourced in United States, Germany, Macao, Canada, Japan, Italy
Drabkin's reagent is a laboratory solution used for the colorimetric determination of hemoglobin concentrations. It consists of a mixture of potassium ferricyanide, potassium cyanide, and sodium bicarbonate. When mixed with a blood sample, the reagent converts hemoglobin into cyanmethemoglobin, which can be measured spectrophotometrically.
Sourced in United States, Japan, United Kingdom, Germany, Belgium, Austria, Italy, Poland, India, Canada, Switzerland, Spain, China, Sweden, Brazil, Australia, Hong Kong
SPSS Statistics is a software package used for interactive or batched statistical analysis. It provides data access and management, analytical reporting, graphics, and modeling capabilities.
Sourced in Germany, United States, France, United Kingdom, Netherlands, Spain, Japan, China, Italy, Canada, Switzerland, Australia, Sweden, India, Belgium, Brazil, Denmark
The QIAamp DNA Mini Kit is a laboratory equipment product designed for the purification of genomic DNA from a variety of sample types. It utilizes a silica-membrane-based technology to efficiently capture and purify DNA, which can then be used for various downstream applications.

More about "Postpartum Hemorrhage"

Postpartum hemorrhage (PPH) is a serious complication that can occur after childbirth, characterized by excessive bleeding from the uterus.
This life-threatening condition requires prompt medical intervention to control the bleeding and prevent complications.
PPH is a critical maternal health issue that can lead to severe blood loss, shock, and even death if not managed effectively.
Related terms and subtopics include: - Uterine atony: Failure of the uterus to contract properly after delivery, a leading cause of PPH. - Retained placenta: When the placenta does not fully separate from the uterine wall, a common cause of PPH. - Uterine inversion: When the uterus turns inside out, a rare but serious complication that can lead to PPH. - Coagulopathy: Abnormal blood clotting that can contribute to excessive bleeding in PPH. - Risk factors: Factors like multiple pregnancies, large babies, and uterine fibroids can increase the risk of PPH.
Utilizing tools like SAS, STATA, Epi Info, SPSS, and the QIAamp DNA Mini Kit can help researchers and clinicians optimize their approach to studying and managing PPH.
PubCompare.ai's AI-driven protocols can further streamline the research process by easily locating the best protocols and products from literature, preprints, and patents using their AI-powered comparisons.
This can help uncover the most relevant information to better understand and address this critical maternal health issue.